Dragana Bugarski‐Kirola

Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: Analysis of CATIE data

Jonathan Rabinowitz, Stephen Z. Levine, George Garibaldi et al. · Schizophrenia Research · 2012 · 359 citations

Psychiatry, Psychotic Disorder, Catie Data +9

Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte Studies

Dragana Bugarski‐Kirola, Thomas Blaettler, Celso Arango et al. · Biological Psychiatry · 2016 · 137 citations

Daylyte Studies, Psychiatry, Psychotic Disorder +10

Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: A CATIE analysis

Jonathan Rabinowitz, Carmen Galani Berardo, Dragana Bugarski‐Kirola et al. · Schizophrenia Research · 2013 · 111 citations · Full text

A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia – Results from the CandleLyte study

Dragana Bugarski‐Kirola, A. Wang, Danielle Abi‐Saab et al. · European Neuropsychopharmacology · 2014 · 94 citations

Psychiatry, Psychotic Disorder, Medicine +10

Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme

Dragana Bugarski‐Kirola, Nakao Iwata, Snjezana Sameljak et al. · The Lancet Psychiatry · 2016 · 91 citations

Psychiatry, Psychotic Disorder, Psychotropic Medication +9